Complex structure of humans eyes found to be similar to those of freshwater apple snail, which can entirely regenerate its ...

Glaucoma UK has announced the three recipients of its 2025 project grants, awarding funding to three research teams ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for ...

Nicox and Kowa entered into an agreemen in February 2024, in which Kowa was granted exclusive Japanese rights to develop and ...

Disc hemorrhage location was associated with areas of clustered visual field progression in patients with primary open-angle ...

Press Release Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan Exclusive Japanese partner Kowa has ...

Slower visual field loss in patients with primary open-angle glaucoma was linked to greater physical activity, suggesting ...

The risk for several ocular and auditory comorbidities is increased in children, adolescents, and adults with vitiligo compared with control patients.

Filtration surgery effectively lowers IOP and slows central visual field deterioration in open-angle glaucoma and high myopia.

Diorasis Therapeutics & Northway Biotech partner to develop and manufacture AAV gene therapy for glaucoma: Boston, Massachusetts Thursday, July 31, 2025, 16:00 Hrs [IST] Diorasis ...